1. Home
  2. SHO vs HRMY Comparison

SHO vs HRMY Comparison

Compare SHO & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SHO

Sunstone Hotel Investors Inc. Sunstone Hotel Investors Inc.

N/A

Current Price

$9.32

Market Cap

1.8B

ML Signal

N/A

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

N/A

Current Price

$28.53

Market Cap

1.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SHO
HRMY
Founded
1995
2017
Country
United States
United States
Employees
36
N/A
Industry
Hotels/Resorts
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.7B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
SHO
HRMY
Price
$9.32
$28.53
Analyst Decision
Hold
Buy
Analyst Count
8
10
Target Price
$9.19
$46.70
AVG Volume (30 Days)
1.5M
1.2M
Earning Date
01-01-0001
05-18-2026
Dividend Yield
3.84%
N/A
EPS Growth
N/A
7.97
EPS
N/A
2.71
Revenue
N/A
$868,453,000.00
Revenue This Year
$3.77
$19.87
Revenue Next Year
$3.58
$12.49
P/E Ratio
$966.33
$10.48
Revenue Growth
N/A
21.51
52 Week Low
$7.45
$25.52
52 Week High
$10.23
$40.87

Technical Indicators

Market Signals
Indicator
SHO
HRMY
Relative Strength Index (RSI) 50.12 32.81
Support Level $8.61 $27.66
Resistance Level $9.35 $37.38
Average True Range (ATR) 0.29 1.66
MACD -0.01 -0.02
Stochastic Oscillator 38.27 27.06

Price Performance

Historical Comparison
SHO
HRMY

About SHO Sunstone Hotel Investors Inc. Sunstone Hotel Investors Inc.

Sunstone Hotel Investors Inc is a real estate investment trust that acquires, owns, manages, and renovates the full-service hotel and select-service hotel properties across various states in the United States. Its firm's portfolio consists upper upscale and luxury hotels located in convention, resort destination and urban markets. Its majority of the hotels operate under a brand owned by Marriott, Hilton, Hyatt, Four Seasons or Montage. It operates geographically in Califiornia which generates the majority of its revenue; Florida; and Hawaii. The company's sole source of income is hotel revenue from its hotel ownership segment.

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Share on Social Networks: